<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">104182</article-id>
<article-id pub-id-type="doi">10.7554/eLife.104182</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.104182.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ImPaqT - A Golden Gate-based Toolkit for Zebrafish Transgenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-1150-0395</contrib-id>
<name>
<surname>Hurst</surname>
<given-names>Saskia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dimmler</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3760-1649</contrib-id>
<name>
<surname>Cronan</surname>
<given-names>Mark R</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<email>cronan@mpiib-berlin.mpg.de</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01hcx6992</institution-id><institution>Humboldt-Universität zu Berlin, Faculty of Life Sciences</institution></institution-wrap>, <city>Berlin</city>, <country country="DE">Germany</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0046gcs23</institution-id><institution>Max Planck Institute for Infection Biology</institution></institution-wrap>, <city>Berlin</city>, <country country="DE">Germany</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Lam</surname>
<given-names>Pui-Ying</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Medical College of Wisconsin</institution>
</institution-wrap>
<city>Wisconsin</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Stainier</surname>
<given-names>Didier YR</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Max Planck Institute for Heart and Lung Research</institution>
</institution-wrap>
<city>Bad Nauheim</city>
<country>Germany</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-03-24">
<day>24</day>
<month>03</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP104182</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-11-05">
<day>05</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-10-05">
<day>05</day>
<month>10</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.08.02.606358"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Hurst et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Hurst et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-104182-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the Tol2 transposon system. Here, we have developed ImPaqT (<bold>Im</bold>munological toolkit for <bold>Paq</bold>CI-based Golden Gate Assembly of Tol2 <bold>T</bold>ransgenes), a new Tol2-based transgenesis system that utilizes Golden Gate assembly to facilitate the production of transgenic zebrafish lines. This system allows for rapid assembly of multiple fragments into a single transgene, facile swapping of individual sequences to generate new transgenes and an easy cloning workflow to incorporate new genetic elements into the existing kit. Within this toolkit framework, we have generated a number of reagents to enable gene expression within immune and non-immune cell types, an array of best-in-class fluorescent proteins to visualize cell populations and transgenes as well as tools to simplify genetic manipulation, purification and ablation of targeted cells. Unlike recombination-based systems, the Golden Gate approach is also expandable, allowing the incorporation of complex designs such as multi-fragment promoters within the established modular framework of ImPaqT. Here, we demonstrate the function of this new system by generating a number of novel transgenic immune reporter lines. While our toolkit is focused on the immune system as an emerging area of study within zebrafish research, the ImPaqT approach can be broadly adapted to the construction of almost any zebrafish transgene, offering new tools for the generation of transgenes within the zebrafish community.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>Tol2 transgenesis</kwd>
<kwd>Golden Gate cloning</kwd>
<kwd>Transgene generation</kwd>
<kwd>Zebrafish</kwd>
<kwd>Immunology</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Revised text and figures for clarity and understanding</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The zebrafish (<italic>Danio rerio</italic>) has emerged as a powerful model organism and is increasingly used in various research fields and disciplines. Zebrafish share 70% of their genome and more than 80% of disease genes with humans (<xref ref-type="bibr" rid="c21">Howe et al. 2013</xref>). This has led to the development of many distinct zebrafish disease models (<xref ref-type="bibr" rid="c41">Santoriello and Zon 2012</xref>) including models of hematopoietic and neurodegenerative diseases, cardiovascular diseases (<xref ref-type="bibr" rid="c5">Bowley et al. 2022</xref>) such as atherosclerosis (<xref ref-type="bibr" rid="c49">Tang et al. 2021</xref>), cancer (<xref ref-type="bibr" rid="c34">Liu and Leach 2011</xref>; <xref ref-type="bibr" rid="c40">Russo et al. 2022</xref>), and tuberculosis (<xref ref-type="bibr" rid="c4">Bouz and Al Hasawi 2018</xref>; <xref ref-type="bibr" rid="c50">Varela and Meijer 2022</xref>), among others. Transgenic animals continue to play a key role for many experimental strategies, including study of gene function, genetic screens, and development of disease models. Transgenic zebrafish lines have been widely generated by applying the Tol2 transposon system with a transgenesis rate of 50% (<xref ref-type="bibr" rid="c28">Kawakami et al. 2004</xref>). In this system, a transposon-donor plasmid containing a DNA sequence of interest flanked by <italic>Tol2</italic> sites and synthetic mRNA encoding the Tol2 transposase are introduced into the single cell of fertilized eggs by microinjection. Upon translation, the transposase protein integrates the <italic>Tol2</italic> flanked gene fragment randomly into the genome through a cut-and-paste mechanism without causing rearrangement or modifications at the target site (<xref ref-type="bibr" rid="c26">Kawakami and Shima 1999</xref>; <xref ref-type="bibr" rid="c27">Kawakami, Shima, and Kawakami 2000</xref>; <xref ref-type="bibr" rid="c28">Kawakami et al. 2004</xref>; <xref ref-type="bibr" rid="c25">Kawakami 2007</xref>).</p>
<p>A number of approaches have previously been used to generate Tol2 transgenesis constructs. Traditionally, multi-step restriction enzyme and ligase based subcloning was used. However, this has given way to many advanced cloning approaches, including Gateway cloning (<xref ref-type="bibr" rid="c17">Hartley, Temple, and Brasch 2000</xref>; <xref ref-type="bibr" rid="c31">Kwan et al. 2007</xref>; <xref ref-type="bibr" rid="c24">Katzen 2007</xref>), Gibson Assembly (<xref ref-type="bibr" rid="c11">Gibson et al. 2009</xref>), In-Fusion cloning (<xref ref-type="bibr" rid="c54">Zhu et al. 2007</xref>; <xref ref-type="bibr" rid="c46">Sleight et al. 2010</xref>) and Golden Gate cloning, which have been used to speed up and simplify the procedure of transgene assembly. Each of these approaches have different advantages and disadvantages. Gateway cloning allows for the establishment and reuse of a library of fragments (e.g. promoters, genes and fluorescent proteins) but requires the use of lambda phage-derived <italic>att</italic> sequences to facilitate insertion of the desired sequences. These <italic>att</italic> sequences result in the addition of ∼20-25 bp of additional sequence in between each element and expansion of the number of fragments to be assembled can require recloning of the sequence with new <italic>att</italic> ends (<xref ref-type="bibr" rid="c24">Katzen 2007</xref>; <xref ref-type="bibr" rid="c10">Engler, Kandzia, and Marillonnet 2008</xref>; <xref ref-type="bibr" rid="c47">Sone et al. 2008</xref>). By contrast, Gibson and In-Fusion cloning allow for joining of short (15-20 bp) regions of homology, enabling the seamless cloning of many transgenes. However, the requirement for homology for seamless cloning generally means that individual components have to be adapted to upstream and downstream elements to generate new transgenes and have an upper limit of approximately 5-6 fragments with currently available kits. Golden Gate cloning utilizes type IIS restriction enzymes to cleave and join multiple fragments in a one pot reaction (<xref ref-type="bibr" rid="c38">Padgett and Sorge 1996</xref>; <xref ref-type="bibr" rid="c10">Engler, Kandzia, and Marillonnet 2008</xref>). It balances the tradeoffs of the previous cloning systems, requiring inclusion of only a short 4 base pair sequence, while enabling researchers to generate a library of vectors that can be combinatorially assembled to generate distinct transgenes. Large numbers of DNA fragments can also be assembled by Golden Gate with reports of assembly of up to 52 fragments in a single reaction (<xref ref-type="bibr" rid="c39">Pryor et al. 2022</xref>). Despite the advantages of Golden Gate cloning, this approach has not been widely applied in zebrafish transgene assembly. Only a few examples of this approach have been described for Tol2 transgenesis including the recently described GoldenFish toolkit which uses Golden Gate cloning to gain more flexibility in transgene design (<xref ref-type="bibr" rid="c23">Jiang et al. 2023</xref>) and the Golden Gateway tool (<xref ref-type="bibr" rid="c29">Kirchmaier, Lust, and Wittbrodt 2013</xref>) which combines the well-established cloning tools Gateway and Golden Gate cloning to simplify creation of new components for Gateway assembly of transgenes.</p>
<p>Here, we have sought to apply Golden Gate cloning approaches to create a toolkit for zebrafish transgenesis. We have developed ImPaqT, a new <bold>Im</bold>munological toolkit for <bold>Paq</bold>CI-based Golden Gate Assembly of Tol2 <bold>T</bold>ransgenes, to facilitate the production of transgenic animals. Studies of immune function have been of growing interest in the zebrafish community due to the close genetic similarity of the immune systems of humans and zebrafish (<xref ref-type="bibr" rid="c21">Howe et al. 2013</xref>), but there are few compiled resources for these cell types. ImPaqT provides a collection of commonly used immunological promoters targeting distinct lineages of vertebrate immunity, genetic tools and fluorophores supporting flexible generation of transgenes for immunological research. This toolkit utilizes Golden Gate cloning due to the advantages of this technique and incorporates a newly described type IIS restriction enzyme, PaqCI, with a 7 base recognition sequence to reduce the frequency of off target cutting (from 1 in 4,096 bases (4<sup>6</sup>) for a 6-base cutter to 1 in 16,384 bases (4<sup>7</sup>), assuming random cutting). We designed the kit to have consistent overhang sequences for each position in the backbone (e.g. 5’, middle, and 3’ element) in order to make the toolkit modular and simplify the construction of additional transgenes. As proof-of-concept, we show that this toolkit can facilitate the production of expression constructs and we demonstrate the generation of transgenic animals using the Tol2 transgenesis with these constructs. ImPaqT is modular, enabling easy swapping of gene sequences, easily expandable, allowing the introduction of multiple new genetic elements if needed, and relies only on the use of short (4 bp) overlaps that can also be designed to be scarless if desired. To establish an immunological toolkit that will be broadly useful to zebrafish researchers, we have generated a variety of immunological and non-immunological promoters, including <italic>mfap4</italic> (macrophages), <italic>irg1</italic> (macrophages, induced by infection), <italic>lyz</italic> (neutrophils), <italic>lck</italic> (T cells), <italic>ubb</italic> (ubiquitious) <italic>and hsp70</italic> (heat shock inducible), tools for genetic recombination (<italic>icre</italic>), cell killing (<italic>kid, nitroreductase)</italic> and cell isolation tools (<italic>LNGFR</italic>), and an array of fluorescence proteins including <italic>mTurquoise2, tdStayGold, mCitrine, mNeonGreen, dLanYFP</italic> and td<italic>Tomato</italic> that can be used to rapidly develop new transgenes and new transgenic lines.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>PaqCI-based Golden Gate cloning enables the construction of Tol2 expression vectors</title>
<p>We sought to create a toolkit for immune transgene construction for the zebrafish community. Ultimately, we decided to design this toolkit to use Golden Gate cloning, given the short regions of homology that this approach required, the ability to structure this toolkit in a modular fashion and the expandability of the Golden Gate cloning approach, enabling incorporation of additional genetic elements as needed. Golden Gate assembly uses type IIS restriction enzymes to generate a set of unique overhangs that are used to join fragments in a desired order. To create a system for modular cloning of transgenes, we chose consistent 4-base overhang sequences for each of the three elements such that DNA fragments amplified with these overhangs can be cloned in the same position in the final construct, allowing these elements to be used combinatorially. As zebrafish transgenes generally consist of a cell-type specific promoter, a gene of interest, and a fluorescent marker, we structured our toolkit to have three elements that would ultimately be joined within a backbone vector possessing Tol2 repeats for transgenesis. These elements were named based on their location within the final construct - 5’ element (5E) for the first position, a middle element (ME) and a 3’ element (3E) for the final position within the backbone.</p>
<p>To generate the overhangs required to join individual components for Golden Gate assembly, we chose the 7-base cutter PaqCI to limit off-target cutting of inserts used in assembly. Genes and regions of interest were generated by PCR amplification using primers containing the 7-base PaqCI recognition sequence along with a spacer consisting of any four nucleotides that will be excised from the final construct, and a 4-base overhang sequence specific to the location of the sequence of interest in the final construct (Fig. S1). These PCR products were cloned into vectors and sequence verified to generate a stable library of constructs for transgene assembly. Cleavage with PaqCI leads to the creation of specific 4-base overhangs for each position at their 5’ and 3’ end enabling proper assembly and single-step ligation into a backbone vector for transgene generation. These backbone vectors possess inverted <italic>Tol2</italic> repeats for transgenesis surrounding a PaqCI-flanked LacZ gene for blue-white screening to identify backbone constructs containing transgene components. A simplified schematic for the assembly using one insert is illustrated in <xref rid="fig1" ref-type="fig">Fig. 1</xref>. As we demonstrated below, we have found that this approach allows for efficient, combinatorial transgene generation.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Basic principles of Golden Gate cloning for Tol2 Transgenesis</title>
<p>Schematic of a Golden Gate cloning reaction using one insert. The insertion construct and backbone vector are assembled in a single-tube reaction using PaqCI and ligase. PaqCI is a type IIS restriction enzyme. Its recognition site and cleavage are indicated. The font color corresponds to the color of the respective feature indicated in the cartoon. The backbone vector consists of Tol2 sites, PaqCI recognition sites (PaqCI) along with 4-base spacer sequences (N<sub>4</sub>) and two overhangs (O). The insertion construct includes the gene of interest (GOI) flanked by PaqCI, N<sub>4</sub> and the same two overhangs. Assembly involves digestion of backbone and insertion constructs by PaqCI producing matching overhangs and ligation through the DNA ligase forming the final assembly product.</p></caption>
<graphic xlink:href="606358v2_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b">
<title>ImPaqT facilitates the flexibility of transgenes design and the generation of transgenic zebrafish</title>
<p>Having established this Golden Gate cloning-based technique for the assembly of Tol2 transposon vectors, we sought to create an array of constructs that would be beneficial to the immunology community to generate transgenic animals. To these ends, we have generated constructs for expression in commonly studied zebrafish immune populations, including T cells (<italic>lck</italic>) (<xref ref-type="bibr" rid="c33">Langenau et al. 2004</xref>), neutrophils (<italic>lyz)</italic> (<xref ref-type="bibr" rid="c14">Hall et al. 2007</xref>) and macrophages (<italic>mfap4</italic> and the infection-inducible <italic>irg1</italic>) (<xref ref-type="bibr" rid="c51">Walton et al. 2015</xref>; <xref ref-type="bibr" rid="c15">Hall et al. 2013</xref>). To enable lineage tracing approaches for labeling of hematopoietic derived cells, we also included the hematopoietic stem cell (HSC)-specific promoter <italic>runx1 +23</italic> (<xref ref-type="bibr" rid="c48">Tamplin et al. 2015</xref>) as well as tools for broader expression including the ubiquitious promoter <italic>ubiquitin B</italic> (<italic>ubb</italic>) (<xref ref-type="bibr" rid="c37">Mosimann et al. 2011</xref>), and the temperature inducible heat shock protein 70-like promoter (<italic>hsp70</italic>) (<xref ref-type="bibr" rid="c45">Shoji, Yee, and Kuwada 1998</xref>; <xref ref-type="bibr" rid="c16">Halloran et al. 2000</xref>; <xref ref-type="bibr" rid="c31">Kwan et al. 2007</xref>). We have also integrated a number of tools to allow for manipulation of these immune populations, including tools for genetic manipulation (<italic>icre</italic> (<xref ref-type="bibr" rid="c44">Shimshek et al. 2002</xref>)), for rapid purification of cell populations (truncated human <italic>LNGFR</italic> (<xref ref-type="bibr" rid="c52">Wattrus and Zon 2020</xref>)) and cell-specific ablation (<italic>nitroreductase</italic> (<xref ref-type="bibr" rid="c6">Curado et al. 2007</xref>; <xref ref-type="bibr" rid="c7">Curado, Stainier, and Anderson 2008</xref>) and <italic>kid</italic> (<xref ref-type="bibr" rid="c32">Labbaf et al. 2022</xref>)). To visualize labeled cell populations and genes, we provide a diverse array of best-in-class fluorescent proteins in a range of colors to facilitate simultaneous imaging of distinct cell types. These include <italic>tdStayGold</italic> (<xref ref-type="bibr" rid="c19">Hirano et al. 2022</xref>), <italic>mTurquoise2</italic> (<xref ref-type="bibr" rid="c12">Goedhart et al. 2012</xref>), <italic>tdTomato</italic> (<xref ref-type="bibr" rid="c42">Shaner et al. 2004</xref>), m<italic>Citrine</italic> (<xref ref-type="bibr" rid="c53">Zacharias et al. 2002</xref>), <italic>mNeonGreen</italic> (<xref ref-type="bibr" rid="c43">Shaner et al. 2013</xref>) and <italic>dLanYFP</italic> (<xref ref-type="bibr" rid="c43">Shaner et al. 2013</xref>). A summary of all available constructs is shown in <xref rid="tbl1" ref-type="table">Table 1</xref>. ImPaqT is also designed to be easily expandable through simple cloning approaches.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Library of insertion constructs.</title>
<p>5’ element (5E), middle element (ME), 3’ element (3E).</p></caption>
<graphic xlink:href="606358v2_tbl1.tif" mime-subtype="tiff" mimetype="image"/>
<graphic xlink:href="606358v2_tbl1a.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
</sec>
<sec id="s2c">
<title>Generation of new transgenic zebrafish lines using ImPaqT</title>
<p>To test our PaqCI-based Golden Gate assembly toolkit as well as generate new immunological zebrafish lines for the community, we used ImPaqT to assemble a number of new transgenic lines. Using the neutrophil-specific promoter <italic>lyz</italic>, we generated a T<italic>g(lyz:mTurquoise2)</italic><sup><italic>ber2</italic></sup> construct through Golden Gate assembly of 5E <italic>lyz</italic>, ME <italic>mTurquoise2</italic> and 3E <italic>ubb:polyA</italic> to create the <italic>lyz:</italic>m<italic>Turquoise2</italic> transgene construct (<xref rid="fig2" ref-type="fig">Fig. 2A-B</xref>). The construct was coinjected with <italic>Tol2</italic> transposase mRNA into single cell of fertilized eggs and at 2 dpi we observed strong blue fluorescence signal within likely neutrophil populations in the CHT (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). Positive animals were raised to adulthood and screening of F1 progeny of these animals revealed robust expression of mTurquoise2 within putative neutrophil populations throughout the animal (<xref rid="fig2" ref-type="fig">Fig. 2D</xref>). Crossing to the already established neutrophil reporter <italic>Tg(lyz:EGFP)</italic><sup><italic>nz117</italic></sup> (<xref ref-type="bibr" rid="c14">Hall et al. 2007</xref>) zebrafish confirmed specific expression of our transgene within neutrophils (Fig. S2).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Generation of <italic>Tg(lyz:mTurquoise2)</italic> zebrafish</title>
<p>A: Schematic of the Golden Gate assembly of <italic>Tg(lyz:mTurquoise2)</italic>. The backbone vector contains overhang sequences O1 (TTCC) and O4 (AGGA). <italic>lyz</italic> is a neutrophil-specific promoter containing overhang sequences O1 and O2 (CAAA). <italic>mTurquoise2</italic> encodes a bright cyan fluorescent protein with overhangs O2 and O3 (GCTA). <italic>ubb:polyA</italic> is assembled at the final position within the backbone with O3 and O4.B: Schematic of the final assembly product of <italic>Tg(lyz:mTurquoise2)</italic>. C-D: Images of a <italic>Tg(lyz:mTurquoise2)</italic> F0 (C) and F1 (D) larva showing neutrophil response in cyan at 2 days post fertilization.</p></caption>
<graphic xlink:href="606358v2_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Similarly, we used the ImPaqT toolkit to generate a new macrophage-specific transgene using the infection-inducible macrophage-specific promoter <italic>irg1</italic> and the recently described bright green fluorescent protein <italic>tdStayGold</italic> (<xref ref-type="bibr" rid="c19">Hirano et al., 2022</xref>). To generate the <italic>Tg(irg1:tdStayGold)</italic><sup><italic>ber3</italic></sup> construct, the 5E <italic>irg1</italic>, ME <italic>tdStayGold</italic> and 3E <italic>ubb:polyA</italic> elements were combined into the backbone vector (<xref rid="fig3" ref-type="fig">Fig. 3 A-B</xref>). We injected zebrafish with this construct and as <italic>irg1</italic> is an inflammation responsive promoter that is only weakly expressed in the absence of immune stimulation, we injected larvae with LPS before screening. After LPS injection, we were able to identify a number of F0 founders with strong green fluorescence within subpopulations of their macrophages (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). These positive F0 larvae were raised to adulthood and screening of F1 progeny revealed expression of tdStayGold throughout macrophage populations upon stimulation with LPS (<xref rid="fig3" ref-type="fig">Fig. 3 D</xref>).</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Generation of <italic>Tg(irg1:tdStayGold)</italic> zebrafish</title>
<p>A: Schematic of the Golden Gate assembly of <italic>Tg(irg1:tdStayGold)</italic>. The backbone vector contains overhang sequences O1 (TTCC) and O4 (AGGA). <italic>irg1</italic> is a macrophage-specific promoter containing overhang sequences O1 and O2 (CAAA). <italic>tdStayGold</italic> encodes a bright green fluorescent protein with overhangs O2 and O3 (GCTA). <italic>ubb:polyA</italic> is assembled at the final position within the backbone with O3 and O4. B: Illustration of the final assembly product of <italic>Tg(irg1:tdStayGold)</italic>. C-D: Images of a <italic>Tg(irg1:tdStayGold)</italic> F0 (C) and F1 (D) larva showing macrophage-specific tdStayGold expression.</p></caption>
<graphic xlink:href="606358v2_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>We also aimed to test the utility of the tools that we have designed within our kit. To these ends, we created an infection-inducible, macrophage specific <italic>icre</italic> transgene construct, <italic>Tg(irg1:icre-p2A mTurquoise2)</italic>. This construct was generated by combining the 5E <italic>irg1</italic>, ME <italic>icre</italic> and 3E <italic>p2A mTurquoise2</italic> (<xref rid="fig4" ref-type="fig">Fig. 4A</xref> and <xref ref-type="fig" rid="fig4">4B</xref>). Animals injected with this transgene showed macrophage-specific mTurquoise2 signal after injection with LPS (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>). To further confirm that this construct was able to drive rearrangement of floxed reporters, we injected <italic>Tg(−3</italic>.<italic>5ubb:LOXP-EGFP-LOXP-mCherry)</italic><sup><italic>cz1701</italic></sup> (<xref ref-type="bibr" rid="c37">Mosimann et al. 2011</xref>) zebrafish with this construct. These animals were injected with LPS and imaged for 48 h to visualize rearrangement of the floxed construct. LPS treatment drove the induction of <italic>icre</italic> and the co-translationally cleaved <italic>p2a mTurquoise2</italic> transgene within macrophages starting ca. 4 h post LPS injection. While the induction of the <italic>irg1:icre-p2a mTurquoise2</italic> transgene was transitory, this short-term induction of Cre could induce permanent rearrangement of the <italic>loxP-EGFP-loxP-mCherry</italic> construct as seen by induction of red fluorescent mCherry within macrophage populations (<xref rid="fig4" ref-type="fig">Fig. 4D</xref>, S3, Movie S1). Control animals without the <italic>icre</italic>-construct neither showed mTurquoise2 nor mCherry signal in macrophages (Fig. S3, Movie S 2). This experiment showed not only the functionality of the individual insertion constructs but also the range of assembly constructs that can be generated with them.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Generation of <italic>Tg(irg1:icre-p2A mTurquoise2)</italic> zebrafish for lineage tracing of individual macrophages</title>
<p>A: Schematic of the Golden Gate assembly of <italic>Tg(irg1:icre-p2A mTurquoise2)</italic>. The backbone vector contains overhang sequences O1 (TTCC) and O4 (AGGA). The macrophage promoter <italic>irg1</italic> contains overhang sequences O1 and O2 (CAAA). <italic>icre</italic> contains overhangs O2 and O3 (GCTA) for the middle position. <italic>p2A mTurquoise2</italic> is assembled at the final position within the backbone with O3 and O4. B: Illustration of the final assembly product of <italic>Tg(irg1:icre-p2A mTurquoise2)</italic>. C: Image of a <italic>Tg(irg1:icre-p2A mTurquoise2)</italic> F0 larva showing macrophage-specific mTurquoise2 signal after stimulation with LPS. D: Images of a <italic>Tg(−3</italic>.<italic>5ubb:LOXP-EGFP-LOXP-mCherry)</italic> larva that was introduced to the <italic>Tg(irg1:icre-p2A mTurquoise2)</italic> construct at single cell stage and was treated with PTU and LPS. The images show a macrophage-specific mTurquoise2 signal (e.g. 5 h post LPS injection) and a macrophage-specific mCherry signal (e.g. 33 h post LPS injection).</p></caption>
<graphic xlink:href="606358v2_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2d">
<title>ImPaqT is expandable through the introduction of new overhang sequences</title>
<p>A limitation of many existing systems for transgenesis is that these systems have a fixed number of elements that can be combined to generate transgenes. Golden Gate methods however, are expandable through the addition of new overhangs and have been used to join 10-24 or even more than 50 fragments of DNA in a single reaction (<xref ref-type="bibr" rid="c30">Kucera 2021</xref>; <xref ref-type="bibr" rid="c39">Pryor et al. 2022</xref>). The ability to expand this kit to include larger numbers of constructs would simplify the generation of complex transgenes including multifragment promoters, loxP sites, localization tags (e.g NLS or prenylation signal) or multigene constructs for example. To provide proof of concept for the expandability of ImPaqT, vectors were designed to enable the construction of a <italic>ubb</italic> promoter-driven construct from three similar sized <italic>ubb</italic> promoter fragments, <italic>ubb</italic><sub><italic>1</italic></sub>, <italic>ubb</italic><sub><italic>2</italic></sub> and <italic>ubb</italic><sub><italic>3</italic></sub>. These fragments were constructed such that the first fragment (<italic>ubb</italic><sub><italic>1</italic></sub>) and the last fragment (<italic>ubb</italic><sub><italic>3</italic></sub>) use the same O1 and O2 overhangs used by 5E constructs so that the array of promoter fragments can be cloned into the existing position of 5E elements and used alongside already existing ME and 3E constructs (<xref rid="fig5" ref-type="fig">Fig. 5A-B</xref>). New internal overhangs were designed for the <italic>ubb</italic><sub><italic>1</italic></sub>, <italic>ubb</italic><sub><italic>2</italic></sub> and <italic>ubb</italic><sub><italic>3</italic></sub> fragments to combine these distinct fragments (<xref rid="fig5" ref-type="fig">Fig. 5A-D</xref>). Individual <italic>ubb</italic> fragments were used for Golden Gate assembly in combination with ME <italic>mTurquoise2</italic> and 3E <italic>ubb:polyA</italic> (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>) which led to the expected transgenesis construct <italic>Tg(ubb:mTurquoise2)</italic><sup><italic>ber4</italic></sup> (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>) that was injected into embryos at single cell stage. Screening of injected animals confirmed that transgenic embryos established with this construct had the expected expression pattern (<xref rid="fig5" ref-type="fig">Fig. 5E</xref>). We also found robust expression in the F1 progeny (<xref rid="fig5" ref-type="fig">Fig. 5F</xref>) after raising positive F0 animals, confirming that injected animals are viable and able to pass on the transgene to the next generation. Together, these findings demonstrated proof-of-concept for the expansion of this transgene assembly system enabling users to add fragments as needed through the addition of novel unique 4-base overhangs while maintaining compatibility with existing ImPaqT constructs.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5.</label>
<caption><title>ImPaqT allows for expandability of individual positions while retaining compatibility with already established transposon components.</title>
<p>A: Schematic of the 5E <italic>ubiquitin B</italic> (<italic>ubb</italic>) promoter construct containing PaqCI recognition sites (PaqCI) along with 4-base spacer sequences (N<sub>4</sub>) and two overhangs (O1: TTCC, O2: CAAA) for positioning at the 5’ end of the assembly construct. Primers were designed to break up <italic>ubb</italic> into three fragments with new overhang sequences. B: Schematic of PCR amplified <italic>ubb</italic> fragments <italic>ubb</italic><sub><italic>1-3</italic></sub> with PaqCI, N<sub>4</sub> and O1 and O1A (TAGC), O1A and O1B (TTGA), and O1B and O2, respectively. C: Schematic of the Golden Gate assembly of 5E <italic>ubb</italic><sub><italic>1-3</italic></sub>, ME <italic>mTurquoise2</italic> and 3E <italic>ubb:polyA</italic> into the backbone vector. D: Illustration of the final assembly product of <italic>Tg(ubb</italic><sub><italic>1-3</italic></sub><italic>:mTurquoise2)</italic>. E-F: Images of a <italic>Tg(ubb:mTurquoise2)</italic> F0 (E) and F1 (F) larva showing ubiquitous mTurquoise2 signal.</p></caption>
<graphic xlink:href="606358v2_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Transgenic animals remain essential for many research questions. They enable the visualization of cells and tissues, molecular pathways, immune responses and the perturbation of these pathways to identify the molecular mechanisms driving pathology. Use of the zebrafish as a model organism has been steadily increasing in many research disciplines due to the unique advantages of this model. This is true in immunology and host-pathogen interactions, where the optical transparency afforded by the zebrafish model have led to many research discoveries, but where, as a new immunology model, there are limited transgenic tools. Here, we demonstrate a new cloning toolkit for the generation of immunological transgenes that is based on Golden Gate cloning. The Golden Gate approach results in shorter overlap regions (4 bp) than recombination-based techniques like Gateway cloning, while compared to seamless, homology based cloning methods such as Gibson cloning, it allows for straightforward modular cloning approaches. The Golden Gate approach also takes advantage of off-the-shelf restriction enzymes and ligase, compared to other cloning approaches which use proprietary enzymes for cloning.</p>
<p>We have termed this toolkit ImPaqT - <bold>Im</bold>munological toolkit for <bold>Paq</bold>CI-based Golden Gate Assembly of Tol2 <bold>T</bold>ransgenes. It includes a range of immunologically focused promoters along with genetic tools and fluorescent proteins that can be assembled using PaqCI-based Golden Gate cloning. These tools will enable the flexible assembly of transgenes to drive expression and to genetically manipulate, purify and ablate immune cell populations of interest. While zebrafish possess the same immune lineages of other vertebrates, as a relatively new model for immunology studies, the zebrafish has a more limited array of cell type-specific promoters than mouse models. For instance, despite the identification of potential NK- and ILC-specific (<xref ref-type="bibr" rid="c18">Hernandez et al. 2018</xref>) as well as mast cell-specific (<xref ref-type="bibr" rid="c9">Dobson et al. 2008</xref>) genes, promoters specific for these cell populations have not been described. As new immune-specific promoters are identified, these can be readily added to this toolkit. While we have targeted the immune system as a particular area of need, this Golden Gate approach can also be adapted to any other tissue or cell lineages within the zebrafish.</p>
<p>While Golden Gate cloning enables the use of shorter homology stretches and the combinatorial use of constructs for the assembly of diverse transgenes, as a restriction enzyme-based system, a limitation of Golden Gate systems, compared to other assembly approaches, has been the risk of off-target cutting within the cloned sequences. This off-target cutting requires mutation of insert sequences to eliminate these sites (termed domestication), (<xref ref-type="bibr" rid="c35">Marillonnet and Grutzner 2020</xref>; <xref ref-type="bibr" rid="c3">Bird, Marles-Wright, and Giachino 2022</xref>; <xref ref-type="bibr" rid="c13">Grützner and Marillonnet 2020</xref>), which can potentially alter function of domesticated promoters and genes. While domestication can result in changes in the sequence that may alter behavior of the genetic element, these in principle can be managed for genes of interest using silent mutations in critical bases. While promoters cannot be managed through the same approach, promoter fragments used for zebrafish are frequently large (commonly 2-6 kb) and it is unlikely that the mutation of a single base pair will inadvertently ablate the promoter activity. Consistent with this, we have not seen any changes in promoter activity or localization in the two promoters that we domesticated for the ImPaqT toolkit, although further cloning of additional promoters will more completely test this idea. Our choice of PaqCI itself seeks to address the limitations of domestication, as PaqCI uses a 7 base recognition site. In contrast to the 6 base-cutters that have been described in previous zebrafish Golden Gate approaches (<xref ref-type="bibr" rid="c29">Kirchmaier, Lust, and Wittbrodt 2013</xref>; <xref ref-type="bibr" rid="c23">Jiang et al. 2023</xref>), the rare cutting of PaqCI (if random, 1 in 16,384 bases) makes this enzyme better suited for the large DNA fragments that are frequently used for zebrafish promoters.</p>
<p>A limitation of existing systems has been the use of a fixed number of constructs for assembly of the transgene. One benefit of the Golden Gate directed system is that it can be expanded for cloning of complex transgenes, with some Golden Gate assemblies encompassing 20 or even more than 50 fragments (<xref ref-type="bibr" rid="c30">Kucera 2021</xref>; <xref ref-type="bibr" rid="c39">Pryor et al. 2022</xref>). While we have designed the system to incorporate 4 distinct DNA segments (3 inserts and a backbone vector) the flexibility of Golden Gate cloning means that our system can be readily expanded and contracted while maintaining compatibility with the other components of the kit. As proof-of-concept, we were able to break a single 5E encoding the <italic>ubb</italic> promoter into 3 distinct plasmids that we could subsequently assemble together with existing ME, 3E and backbone elements to generate a functional <italic>ubb</italic> driven transgene. The flexibility of this system will simplify the construction of large and complex transgenes. Potential applications would include breaking up larger promoter fragments into smaller and easier to clone elements, insertion of recombination sites for enzymes like Cre or Flp for rearrangement, assembly of multipromoter constructs encoding genes such as Cas9 and CRISPR gRNAs for cell type-specific knockout, or the inclusion of epitope or localization tags.</p>
<p>Lastly, while we have applied this Golden Gate method for the construction of Tol2 transgenes, the advantages of the PaqCI-Golden Gate method will likely be useful for the editing of zebrafish by other approaches as well. For instance, CRISPR insertion has been increasingly used to generate knock-in zebrafish lines, via either homologous recombination, non-homologous methods or by using short homology stretches. Knock-in approaches require the construction of donor vectors which incorporate varied sequences such as homology regions, fluorescent proteins and stretches of genomic DNA (<xref ref-type="bibr" rid="c1">Albadri, Del Bene, and Revenu 2017</xref>). Similarly, many groups also use I-SceI insertion approaches to generate transgenic zebrafish (<xref ref-type="bibr" rid="c20">Hoshijima, Jurynec, and Grunwald 2016</xref>). The PaqCI Golden Gate method could be adapted to simplify the construction of transgenes and editing constructs for these other approaches as well.</p>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Zebrafish husbandry and experiments were approved by the “Landesamt für Gesundheit und Soziales” (LaGeSo) Berlin (Germany).</p>
</sec>
<sec id="s4b">
<title>Zebrafish husbandry and handling</title>
<p>Zebrafish (<italic>Danio rerio</italic>) embryos were raised in petri dishes containing E3 medium at 28°C for up to five days. Animals older than 5 days were maintained in a circulating system with constant water conditions of 28°C, pH 7.0 - 7.3, and a conductivity of 600-700 µS on a 12-hour light/ 12-hour dark cycle. They were fed twice a day with artemia and once a day with dry food.</p>
</sec>
<sec id="s4c">
<title>Generation of transgenic zebrafish lines</title>
<sec id="s4c1">
<title>Zebrafish strains</title>
<p>All zebrafish strains, including <italic>Tg(lyz:mTurquoise2)</italic><sup><italic>ber2</italic></sup>, <italic>Tg(irg1:tdStayGold)</italic><sup><italic>ber3</italic></sup>,<italic>Tg(irg1:icre-p2A mTurquoise2)</italic> and <italic>Tg(ubb:mTurquoise2)</italic><sup><italic>ber4</italic></sup>, were in the <sup>*</sup>AB wildtype background and generated in this study by applying the Tol2 transgenesis system as previously described (<xref ref-type="bibr" rid="c28">Kawakami et al., 2004</xref><italic>). Tg(−3</italic>.<italic>5ubb:LOXP-EGFP-LOXP-mCherry)</italic><sup><italic>cz1701</italic></sup> zebrafish were obtained from the European Zebrafish Resource Center (EZRC). <italic>Tg(−3</italic>.<italic>5ubb:LOXP-EGFP-LOXP-mCherry)</italic><sup><italic>cz1701</italic></sup> (<xref ref-type="bibr" rid="c37">Mosimann et al. 2011</xref>) and <italic>Tg(lyz:EGFP)</italic><sup><italic>nz117</italic></sup> (<xref ref-type="bibr" rid="c14">Hall et al. 2007</xref>) have been previously described.</p>
</sec>
<sec id="s4c2">
<title>Preparation of the backbone vector and inserts</title>
<p>The backbone vector containing the LacZ gene flanked by PaqCI sites and <italic>Tol2</italic> arms in a vector backbone with a pMB1 origin and an AmpR gene for bacterial selection (pTWIST Amp High Copy) was purchased from Twist Bioscience. The complete sequence is shown in Figure S4. Primer sequences are shown in Table S1. Gene fragments for <italic>runx1+23</italic> (with the endogenous PaqCI site mutated), <italic>tdStayGold</italic> and truncated human <italic>LNGFR</italic> (zebrafish codon optimized and with endogenous PaqCI sites mutated) were purchased from Twist Bioscience and TOPO cloned into pCRII TOPO (Thermofisher Zero Blunt TOPO). The complete sequences are shown in Figure S5.</p>
<p>PaqCI recognition sites with 4-base spacer sequences and 4-base overhangs were added to DNA sequences via PCR amplification. Primer were designed to add PaqCI sites such as cleavage resulted in a gene fragment with a 4-base overhang that is compatible to the overhang of another gene fragment that will be adjacent to it in the final assembly. Appropriate 4-base overhang sequences were confirmed using the online tool NEBridge Ligase Fidelity Viewer<sup>™</sup>. PCR amplification was performed using Q5 polymerase and analyzed by gel electrophoresis. The PCR product was cleaned up or, in case of multiple bands, the band of correct size was excised under 70% UV light using a clean scalpel and DNA was extracted using Nucleo Spin Gel and PCR Clean-up Kit (Macherey-Nagel). DNA sequences were confirmed by sequencing. Gel purified gene fragments were subcloned into a Zero Blunt TOPO vector (Invitrogen) and transformed into competent NEB 5α <italic>E. coli</italic> cells (C2987H). Cells were cultivated in LB medium containing 50 µg/ml Kanamycin and plasmids were isolated using the Nucleo Spin Plasmid Quick Pure protocol (Macherey-Nagel).</p>
<p>Both the <italic>ubb</italic> and <italic>lck</italic> promoters had endogenous PaqCI cleavage sites in the promoter sequence. To domesticate these promoters, we mutated these PaqCI sites with the indicated PCR primers (Table S1) and assembled them with In-Fusion cloning (Takara Bio).</p>
</sec>
<sec id="s4c3">
<title>Golden Gate based assembly of expression constructs</title>
<p>Golden Gate assembly was performed according to the NEB protocol. In detail, 75 ng of the backbone vector and each insertion construct was mixed with 10 U PaqCI, 0.5 µl PaqCI activator (20 µM) and 400 U T4 DNA ligase in T4 DNA ligase buffer to a final volume of 20 µl. Final assembly product was obtained after 60 Cycles of incubation at 37°C for 1 min and incubation at 16°C for 1 min, followed by 5 min incubation at 37°C and 5 min incubation at 60°C using a thermocycler. The final product was transformed into competent NEB 5α <italic>E. coli</italic> cells (C2987H) and cells were cultivated in LB medium containing 20 µg/ml Ticarcillin. Plasmids were isolated using the Nucleo Spin Plasmid Quick Pure protocol (Macherey-Nagel) and PCR purified using the Nucleo Spin Gel and PCR Clean-up Kit (Macherey-Nagel) before microinjection.</p>
</sec>
<sec id="s4c4">
<title>Microinjections</title>
<p>The injection mixture contained 25 ng/µL polyadenylated mRNA encoding the Tol2 transposase, 50 ng/µL transposon donor plasmid and 10% phenol red in a final volume of 10 µl 1 X Tango Buffer (Thermo Fisher). The mMessage mMachine kit (Life Technologies) was used to transcribe the mRNA from T3TS-Tol2 (<xref ref-type="bibr" rid="c2">Balciunas et al. 2006</xref>). A volume of ∼1 nL was injected into the single cell of fertilized eggs by using a microinjector.</p>
</sec>
<sec id="s4c5">
<title>Imaging</title>
<p>Injected larvae were screened for insertion of the transgene 2 days post injection (dpi) using a Nikon ECLIPSE Ti2 microscope (Nikon) with a Dragonfly 200 confocal system (Oxford Instruments). Animals that were positive for the transgene were raised to adulthood and outcrossed to the <sup>*</sup>AB wildtype strain for selection of transgenic founder zebrafish. Before screening <italic>Tg(irg1:icre-p2A mTurquoise2)</italic> and <italic>Tg(irg1:tdStayGold)</italic> embryos, the activity of the <italic>irg1</italic> promoter was induced by injection of LPS. For that purpose, animals were anesthetized with tricaine (MS-222) at a final concentration of 0.016% and injected into the caudal vein with LPS (Sigma-Aldrich, F3665) (final: 0.8 mg/ml). Screening was performed at least 4 h after injection. To reduce pigmentation, <italic>Tg(−3</italic>.<italic>5ubb:LOXP-EGFP-LOXP-mCherry)</italic> embryos were treated with 45 µg/ml 1-phenyl-2-thiourea (PTU) starting ca. 20 h post fertilization. Image analysis was performed using the Fiji ImageJ software (National Institute of Health, USA).</p>
</sec>
<sec id="s4c6">
<title>Line and reagent availability</title>
<p>All new lines and plasmids are available from the corresponding author upon contact and will also be deposited to AddGene.</p>
</sec>
</sec>
</sec>

</body>
<back>
<sec id="s7" sec-type="data-availability">
<title>Data availability</title>
<p>All relevant data can be found within the article and its supplementary information.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank Miriam Herbert for sharing the ME <italic>kid</italic> construct. Additionally, we would like to thank our animal welfare officer Antje Dreyer and our animal caretakers Silke Lehmann, Marten Walk, Carsten Weiland, Ines Neumann, Jens-Phillip Otto und Janine Bleske for their great work and support.</p>
</ack>
<sec id="d1e1217" sec-type="additional-information">
<title>Additional information</title>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by the Max Planck Society.</p>
</sec>
</sec>
<sec id="suppd1e1217" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="d1e1194">
<label>Supplementary figures and tables</label>
<media xlink:href="supplements/606358_file02.pdf"/>
</supplementary-material>
<supplementary-material id="d1e1201">
<label>Movie 1</label>
<media xlink:href="supplements/606358_file03.avi"/>
</supplementary-material>
<supplementary-material id="d1e1208">
<label>Movie 2</label>
<media xlink:href="supplements/606358_file04.avi"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Albadri</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Del Bene</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Revenu</surname></string-name></person-group>. <year>2017</year>. <article-title>Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish</article-title>, <source>Methods</source>, <volume>121-122</volume>: <fpage>77</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balciunas</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>K. J.</given-names> <surname>Wangensteen</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Wilber</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bell</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Geurts</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Sivasubbu</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>P. B.</given-names> <surname>Hackett</surname></string-name>, <string-name><given-names>D. A.</given-names> <surname>Largaespada</surname></string-name>, <string-name><given-names>R. S.</given-names> <surname>McIvor</surname></string-name>, and <string-name><given-names>S. C.</given-names> <surname>Ekker</surname></string-name></person-group>. <year>2006</year>. <article-title>Harnessing a high cargo-capacity transposon for genetic applications in vertebrates</article-title>, <source>PLoS Genet</source>, <volume>2</volume>: <fpage>e169</fpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bird</surname>, <given-names>J. E.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Marles-Wright</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Giachino</surname></string-name></person-group>. <year>2022</year>. <article-title>A User’s Guide to Golden Gate Cloning Methods and Standards</article-title>, <source>ACS Synth Biol</source>, <volume>11</volume>: <fpage>3551</fpage>–<lpage>63</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bouz</surname>, <given-names>G.</given-names></string-name>, and <string-name><given-names>N.</given-names> <surname>Al Hasawi</surname></string-name></person-group>. <year>2018</year>. <article-title>The zebrafish model of tuberculosis - no lungs needed</article-title>, <source>Crit Rev Microbiol</source>, <volume>44</volume>: <fpage>779</fpage>–<lpage>92</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bowley</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Kugler</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Wilkinson</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Lawrie</surname></string-name>, <string-name><given-names>F.</given-names> <surname>van Eeden</surname></string-name>, <string-name><given-names>T. J. A.</given-names> <surname>Chico</surname></string-name>, <string-name><given-names>P. C.</given-names> <surname>Evans</surname></string-name>, <string-name><given-names>E. S.</given-names> <surname>Noel</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Serbanovic-Canic</surname></string-name></person-group>. <year>2022</year>. <article-title>Zebrafish as a tractable model of human cardiovascular disease</article-title>, <source>Br J Pharmacol</source>, <volume>179</volume>: <fpage>900</fpage>–<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curado</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>R. M.</given-names> <surname>Anderson</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Jungblut</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Mumm</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Schroeter</surname></string-name>, and <string-name><given-names>D. Y. R.</given-names> <surname>Stainier</surname></string-name></person-group>. <year>2007</year>. <article-title>Conditional Targeted Cell Ablation inZebrafish: A New Tool for RegenerationStudies</article-title>, <source>Developmental Dynamics</source>, <volume>236</volume>: <fpage>1025</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curado</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>D. Y.</given-names> <surname>Stainier</surname></string-name>, and <string-name><given-names>R. M.</given-names> <surname>Anderson</surname></string-name></person-group>. <year>2008</year>. <article-title>Nitroreductase-mediated cell/tissue ablation in zebrafish: a spatially and temporally controlled ablation method with applications in developmental and regeneration studies</article-title>, <source>Nat Protoc</source>, <volume>3</volume>: <fpage>948</fpage>–<lpage>54</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de la Cueva-Mendez</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>A. D.</given-names> <surname>Mills</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Clay-Farrace</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Diaz-Orejas</surname></string-name>, and <string-name><given-names>R. A.</given-names> <surname>Laskey</surname></string-name></person-group>. <year>2003</year>. <article-title>Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis</article-title>, <source>EMBO</source>, <volume>22</volume>: <fpage>246</fpage>–<lpage>51</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobson</surname>, <given-names>J. T.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Seibert</surname></string-name>, <string-name><given-names>E. M.</given-names> <surname>Teh</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Da’as</surname></string-name>, <string-name><given-names>R. B.</given-names> <surname>Fraser</surname></string-name>, <string-name><given-names>B. H.</given-names> <surname>Paw</surname></string-name>, <string-name><given-names>T. J.</given-names> <surname>Lin</surname></string-name>, and <string-name><given-names>J. N.</given-names> <surname>Berman</surname></string-name></person-group>. <year>2008</year>. <article-title>Carboxypeptidase A5 identifies a novel mast cell lineage in the zebrafish providing new insight into mast cell fate determination</article-title>, <source>Blood</source>, <volume>112</volume>: <fpage>2969</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Engler</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Kandzia</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Marillonnet</surname></string-name></person-group>. <year>2008</year>. <article-title>A one pot, one step, precision cloning method with high throughput capability</article-title>, <source>PLoS One</source>, <volume>3</volume>: <fpage>e3647</fpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gibson</surname>, <given-names>D. G.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Young</surname></string-name>, <string-name><given-names>R. Y.</given-names> <surname>Chuang</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Venter</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Hutchison</surname>, <suffix>3rd</suffix></string-name>, and <string-name><given-names>H. O.</given-names> <surname>Smith</surname></string-name></person-group>. <year>2009</year>. <article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title>, <source>Nat Methods</source>, <volume>6</volume>: <fpage>343</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goedhart</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>von Stetten</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Noirclerc-Savoye</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lelimousin</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Joosen</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Hink</surname></string-name>, <string-name><given-names>L.</given-names> <surname>van Weeren</surname></string-name>, <string-name><given-names>T. W.</given-names> <surname>Gadella</surname></string-name>, Jr., and <string-name><given-names>A.</given-names> <surname>Royant</surname></string-name></person-group>. <year>2012</year>. <article-title>Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%</article-title>, <source>Nat Commun</source>, <volume>3</volume>: <fpage>751</fpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Grützner</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>George</surname> <given-names>K. W.</given-names></string-name></person-group>. <year>2020</year>. <chapter-title>Generation of MoClo Standard Parts Using Golden Gate Cloning</chapter-title> <person-group person-group-type="editor"><string-name><surname>Chandran</surname>, <given-names>S.</given-names></string-name>, and <string-name><given-names>S.</given-names> <surname>Marillonnet</surname></string-name></person-group>, <source>DNA Cloning and Assembly Methods and Protocols</source>. <publisher-name>Springer</publisher-name>. <fpage>107</fpage>–<lpage>23</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>M. V.</given-names> <surname>Flores</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Storm</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Crosier</surname></string-name>, and <string-name><given-names>P.</given-names> <surname>Crosier</surname></string-name></person-group>. <year>2007</year>. <article-title>The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish</article-title>, <source>BMC Dev Biol</source>, <volume>7</volume>: <fpage>42</fpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname>, <given-names>C. J.</given-names></string-name>, <string-name><given-names>R. H.</given-names> <surname>Boyle</surname></string-name>, <string-name><given-names>J. W.</given-names> <surname>Astin</surname></string-name>, <string-name><given-names>M. V.</given-names> <surname>Flores</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Oehlers</surname></string-name>, <string-name><given-names>L. E.</given-names> <surname>Sanderson</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Ellett</surname></string-name>, <string-name><given-names>G. J.</given-names> <surname>Lieschke</surname></string-name>, <string-name><given-names>K. E.</given-names> <surname>Crosier</surname></string-name>, and <string-name><given-names>P. S.</given-names> <surname>Crosier</surname></string-name></person-group>. <year>2013</year>. <article-title>Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating beta-oxidation-dependent mitochondrial ROS production</article-title>, <source>Cell Metab</source>, <volume>18</volume>: <fpage>265</fpage>–<lpage>78</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Halloran</surname>, <given-names>M. C.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Sato-Maeda</surname>, <suffix>Jr.</suffix></string-name> <string-name><surname>Warren</surname>, <given-names>J.T.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Lele</surname></string-name>, <string-name><given-names>P. H.</given-names> <surname>Krone</surname></string-name>, <string-name><given-names>J. Y.</given-names> <surname>Kuwada</surname></string-name>, and <string-name><given-names>W.</given-names> <surname>Shoji</surname></string-name></person-group>. <year>2000</year>. <article-title>Laser-induced gene expression in specific cells of transgenic zebrafish</article-title>, <source>Development</source>, <volume>127</volume>: <fpage>1953</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hartley</surname>, <given-names>J. L.</given-names></string-name>, <string-name><given-names>G. F.</given-names> <surname>Temple</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Brasch</surname></string-name></person-group>. <year>2000</year>. <article-title>DNA cloning using in vitro site-specific recombination</article-title>, <source>Genome Res</source>, <volume>10</volume>: <fpage>1788</fpage>–<lpage>95</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernandez</surname>, <given-names>P. P.</given-names></string-name>, <string-name><given-names>P. M.</given-names> <surname>Strzelecka</surname></string-name>, <string-name><given-names>E. I.</given-names> <surname>Athanasiadis</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>A. F.</given-names> <surname>Robalo</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Collins</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Boudinot</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Levraud</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Cvejic</surname></string-name></person-group>. <year>2018</year>. <article-title>Single-cell transcriptional analysis reveals ILC-like cells in zebrafish</article-title>, <source>Sci Immunol</source>, <volume>3</volume>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirano</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Ando</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Shimozono</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sugiyama</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Takeda</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kurokawa</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Deguchi</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Endo</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Haga</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Takai-Todaka</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Inaura</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Matsumura</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Hama</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Okada</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Fujiwara</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Morimoto</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Katayama</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Miyawaki</surname></string-name></person-group>. <year>2022</year>. <article-title>A highly photostable and bright green fluorescent protein</article-title>, <source>Nat Biotechnol</source>, <volume>40</volume>: <fpage>1132</fpage>–<lpage>42</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoshijima</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>M. J.</given-names> <surname>Jurynec</surname></string-name>, and <string-name><given-names>D. J.</given-names> <surname>Grunwald</surname></string-name></person-group>. <year>2016</year>. <article-title>Precise Editing of the Zebrafish Genome Made Simple and Efficient</article-title>, <source>Dev Cell</source>, <volume>36</volume>: <fpage>654</fpage>–<lpage>67</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Howe</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>M. D.</given-names> <surname>Clark</surname></string-name>, <string-name><given-names>C. F.</given-names> <surname>Torroja</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Torrance</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Berthelot</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Muffato</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Collins</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Humphray</surname></string-name>, <string-name><given-names>K.</given-names> <surname>McLaren</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Matthews</surname></string-name>, <string-name><given-names>S.</given-names> <surname>McLaren</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Sealy</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Caccamo</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Churcher</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Scott</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Barrett</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Koch</surname></string-name>, <string-name><given-names>G. J.</given-names> <surname>Rauch</surname></string-name>, <string-name><given-names>S.</given-names> <surname>White</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Chow</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Kilian</surname></string-name>, <string-name><given-names>L. T.</given-names> <surname>Quintais</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Guerra-Assuncao</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Gu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Yen</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Vogel</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Eyre</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Redmond</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Banerjee</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chi</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Langley</surname></string-name>, <string-name><given-names>S. F.</given-names> <surname>Maguire</surname></string-name>, <string-name><given-names>G. K.</given-names> <surname>Laird</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Lloyd</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Kenyon</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Donaldson</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Sehra</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Almeida-King</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Loveland</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Trevanion</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Jones</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Quail</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Willey</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Hunt</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Burton</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Sims</surname></string-name>, <string-name><given-names>K.</given-names> <surname>McLay</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Plumb</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Clee</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Oliver</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Clark</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Riddle</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Elliot</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Threadgold</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Harden</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ware</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Begum</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Mortimore</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Kerry</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Heath</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Phillimore</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Tracey</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Corby</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Dunn</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Johnson</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Wood</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Clark</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Pelan</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Griffiths</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Glithero</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Howden</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Barker</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Lloyd</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Stevens</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Harley</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Holt</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Panagiotidis</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lovell</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Beasley</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Henderson</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Gordon</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Auger</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Wright</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Collins</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Raisen</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Dyer</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Leung</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Robertson</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ambridge</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Leongamornlert</surname></string-name>, <string-name><given-names>S.</given-names> <surname>McGuire</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Gilderthorp</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Griffiths</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Manthravadi</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Nichol</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Barker</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Whitehead</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kay</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Brown</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Murnane</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Gray</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Humphries</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Sycamore</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Barker</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Saunders</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Wallis</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Babbage</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hammond</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mashreghi-Mohammadi</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Barr</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Martin</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Wray</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Ellington</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Matthews</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ellwood</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Woodmansey</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Clark</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Cooper</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Tromans</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Grafham</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Skuce</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Pandian</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Andrews</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Harrison</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kimberley</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Garnett</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Fosker</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Garner</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kelly</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bird</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Palmer</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Gehring</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Berger</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Dooley</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Ersan-Urun</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Eser</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Geiger</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Geisler</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Karotki</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kirn</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Konantz</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Konantz</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Oberlander</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Rudolph-Geiger</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Teucke</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Lanz</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Raddatz</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Osoegawa</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Rapp</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Widaa</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Langford</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>S. C.</given-names> <surname>Schuster</surname></string-name>, <string-name><given-names>N. P.</given-names> <surname>Carter</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Harrow</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Ning</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Herrero</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Searle</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Enright</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Geisler</surname></string-name>, <string-name><given-names>R. H.</given-names> <surname>Plasterk</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Westerfield</surname></string-name>, <string-name><given-names>P. J.</given-names> <surname>de Jong</surname></string-name>, <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Postlethwait</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Nusslein-Volhard</surname></string-name>, <string-name><given-names>T. J.</given-names> <surname>Hubbard</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Roest Crollius</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Rogers</surname></string-name>, and <string-name><given-names>D. L.</given-names> <surname>Stemple</surname></string-name></person-group>. <year>2013</year>. <article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title>, <source>Nature</source>, <volume>496</volume>: <fpage>498</fpage>–<lpage>503</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iwanami</surname>, <given-names>N.</given-names></string-name></person-group> <year>2014</year>. <article-title>Zebrafish as a model for understanding the evolution of the vertebrate immune system and human primary immunodeficiency</article-title>, <source>Exp Hematol</source>, <volume>42</volume>: <fpage>697</fpage>–<lpage>706</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Ni</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Luo</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Yang</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Chen</surname></string-name></person-group>. <year>2023</year>. <article-title>GoldenFish: a rapid and efficient system to customize constructs for zebrafish transgenesis</article-title>, <source>J Mol Cell Biol</source>, <volume>14</volume>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Katzen</surname>, <given-names>F.</given-names></string-name></person-group> <year>2007</year>. <article-title>Gateway((R)) recombinational cloning: a biological operating system</article-title>, <source>Expert Opin Drug Discov</source>, <volume>2</volume>: <fpage>571</fpage>–<lpage>89</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kawakami</surname>, <given-names>K.</given-names></string-name></person-group> <year>2007</year>. <article-title>Tol2: a versatile gene transfer vector in vertebrates</article-title>, <source>Genome Biol</source>, <volume>8</volume> <issue>Suppl 1</issue>: <fpage>S7</fpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kawakami</surname>, <given-names>K.</given-names></string-name>, and <string-name><given-names>A.</given-names> <surname>Shima</surname></string-name></person-group>. <year>1999</year>. <article-title>Identification of the Tol2 transposase of the medaka fish Oryzias latipes that catalyzes excision of a nonautonomous Tol2 element in zebrafish Danio rerio</article-title>, <source>Gene</source>, <volume>240</volume>: <fpage>239</fpage>–<lpage>44</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kawakami</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Shima</surname></string-name>, and <string-name><given-names>N.</given-names> <surname>Kawakami</surname></string-name></person-group>. <year>2000</year>. <article-title>Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage</article-title>, <source>PNAS</source>, <volume>97</volume>: <fpage>11403</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kawakami</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>H.</given-names> <surname>Takeda</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Kawakami</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kobayashi</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Matsuda</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Mishina</surname></string-name></person-group>. <year>2004</year>. <article-title>A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish</article-title>, <source>Dev Cell</source>, <volume>7</volume>: <fpage>133</fpage>–<lpage>44</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kirchmaier</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Lust</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Wittbrodt</surname></string-name></person-group>. <year>2013</year>. <article-title>Golden GATEway cloning--a combinatorial approach to generate fusion and recombination constructs</article-title>, <source>PLoS One</source>, <volume>8</volume>: <fpage>e76117</fpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="report"><person-group person-group-type="author"><string-name><surname>Kucera</surname>, <given-names>R.</given-names></string-name></person-group> <year>2021</year>. <source>Using PaqCI™ for Golden Gate Assembly – What Makes it a Special Addition to NEB’s DNA Assembly Portfolio?</source>. <publisher-name>New England Biolabs</publisher-name></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwan</surname>, <given-names>K. M.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Fujimoto</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Grabher</surname></string-name>, <string-name><given-names>B. D.</given-names> <surname>Mangum</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Hardy</surname></string-name>, <string-name><given-names>D. S.</given-names> <surname>Campbell</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Parant</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>Yost</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Kanki</surname></string-name>, and <string-name><given-names>C. B.</given-names> <surname>Chien</surname></string-name></person-group>. <year>2007</year>. <article-title>The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title>, <source>Dev Dyn</source>, <volume>236</volume>: <fpage>3088</fpage>–<lpage>99</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Labbaf</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Petratou</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Ermlich</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Backer</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Tarbashevich</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Reichman-Fried</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Luschnig</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Schulte-Merker</surname></string-name>, and <string-name><given-names>E.</given-names> <surname>Raz</surname></string-name></person-group>. <year>2022</year>. <article-title>A robust and tunable system for targeted cell ablation in developing embryos</article-title>, <source>Dev Cell</source>, <volume>57</volume>: <fpage>2026</fpage>–<lpage>40 e5</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langenau</surname>, <given-names>D. M.</given-names></string-name>, <string-name><given-names>A. A.</given-names> <surname>Ferrando</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Traver</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Kutok</surname></string-name>, <string-name><given-names>J.-P. D.</given-names> <surname>Hezel</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Kanki</surname></string-name>, <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name>, <string-name><given-names>A. T.</given-names> <surname>Look</surname></string-name>, and <string-name><given-names>N.S</given-names> <surname>Trede</surname></string-name></person-group>. <year>2004</year>. <article-title>In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish</article-title>, <source>PNAS</source>, <volume>101</volume>: <fpage>7369</fpage>–<lpage>74</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name>, and <string-name><given-names>S. D.</given-names> <surname>Leach</surname></string-name></person-group>. <year>2011</year>. <article-title>Zebrafish models for cancer</article-title>, <source>Annu Rev Pathol</source>, <volume>6</volume>: <fpage>71</fpage>–<lpage>93</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marillonnet</surname>, <given-names>S.</given-names></string-name>, and <string-name><given-names>R.</given-names> <surname>Grutzner</surname></string-name></person-group>. <year>2020</year>. <article-title>Synthetic DNA Assembly Using Golden Gate Cloning and the Hierarchical Modular Cloning Pipeline</article-title>, <source>Curr Protoc Mol Biol</source>, <volume>130</volume>: <fpage>e115</fpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meeker</surname>, <given-names>N. D.</given-names></string-name>, and <string-name><given-names>N. S.</given-names> <surname>Trede</surname></string-name></person-group>. <year>2008</year>. <article-title>Immunology and zebrafish: spawning new models of human disease</article-title>, <source>Dev Comp Immunol</source>, <volume>32</volume>: <fpage>745</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mosimann</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>C. K.</given-names> <surname>Kaufman</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>E. K.</given-names> <surname>Pugach</surname></string-name>, <string-name><given-names>O. J.</given-names> <surname>Tamplin</surname></string-name>, and <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name></person-group>. <year>2011</year>. <article-title>Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish</article-title>, <source>Development</source>, <volume>138</volume>: <fpage>169</fpage>–<lpage>77</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Padgett</surname>, <given-names>K. A.</given-names></string-name>, and <string-name><given-names>J. A.</given-names> <surname>Sorge</surname></string-name></person-group>. <year>1996</year>. <article-title>Creating seamless junctions independent of restriction sites in PCR cloning</article-title>, <source>Gene</source>, <volume>168</volume>: <fpage>31</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pryor</surname>, <given-names>J. M.</given-names></string-name>, <string-name><given-names>V.</given-names> <surname>Potapov</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Bilotti</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Pokhrel</surname></string-name>, and <string-name><given-names>G. J. S.</given-names> <surname>Lohman</surname></string-name></person-group>. <year>2022</year>. <article-title>Rapid 40 kb Genome Construction from 52 Parts through Data-optimized Assembly Design</article-title>, <source>ACS Synth Biol</source>, <volume>11</volume>: <fpage>2036</fpage>–<lpage>42</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Russo</surname>, <given-names>I.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Sartor</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Fagotto</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Colombo</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Tiso</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Alaibac</surname></string-name></person-group>. <year>2022</year>. <article-title>The Zebrafish model in dermatology: an update for clinicians</article-title>, <source>Discov Oncol</source>, <volume>13</volume>: <fpage>48</fpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santoriello</surname>, <given-names>C.</given-names></string-name>, and <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name></person-group>. <year>2012</year>. <article-title>Hooked! Modeling human disease in zebrafish</article-title>, <source>J Clin Invest</source>, <volume>122</volume>: <fpage>2337</fpage>–<lpage>43</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shaner</surname>, <given-names>N. C.</given-names></string-name>, <string-name><given-names>R. E.</given-names> <surname>Campbell</surname></string-name>, <string-name><given-names>P. A.</given-names> <surname>Steinbach</surname></string-name>, <string-name><given-names>B. N.</given-names> <surname>Giepmans</surname></string-name>, <string-name><given-names>A. E.</given-names> <surname>Palmer</surname></string-name>, and <string-name><given-names>R. Y.</given-names> <surname>Tsien</surname></string-name></person-group>. <year>2004</year>. <article-title>Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein</article-title>, <source>Nat Biotechnol</source>, <volume>22</volume>: <fpage>1567</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shaner</surname>, <given-names>N. C.</given-names></string-name>, <string-name><given-names>G. G.</given-names> <surname>Lambert</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Chammas</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Ni</surname></string-name>, <string-name><given-names>P. J.</given-names> <surname>Cranfill</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Baird</surname></string-name>, <string-name><given-names>B. R.</given-names> <surname>Sell</surname></string-name>, <string-name><given-names>J. R.</given-names> <surname>Allen</surname></string-name>, <string-name><given-names>R. N.</given-names> <surname>Day</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Israelsson</surname></string-name>, <string-name><given-names>M. W.</given-names> <surname>Davidson</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Wang</surname></string-name></person-group>. <year>2013</year>. <article-title>A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum</article-title>, <source>Nat Methods</source>, <volume>10</volume>: <fpage>407</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shimshek</surname>, <given-names>D. R.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Hubner</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Spergel</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Buchholz</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Casanova</surname></string-name>, <string-name><given-names>A. F.</given-names> <surname>Stewart</surname></string-name>, <string-name><given-names>P. H.</given-names> <surname>Seeburg</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>Sprengel</surname></string-name></person-group>. <year>2002</year>. <article-title>Codon-improved Cre recombinase (iCre) expression in the mouse</article-title>, <source>Genesis</source>, <volume>32</volume>: <fpage>19</fpage>–<lpage>26</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shoji</surname>, <given-names>W.</given-names></string-name>, <string-name><given-names>C. S.</given-names> <surname>Yee</surname></string-name>, and <string-name><given-names>J. Y.</given-names> <surname>Kuwada</surname></string-name></person-group>. <year>1998</year>. <article-title>Zebrafish Semaphorin Z1a collapses specific growth cones and alters their pathway in vivo</article-title>, <source>Development</source>, <volume>125</volume>: <fpage>1275</fpage>–<lpage>83</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sleight</surname>, <given-names>Sean C.</given-names></string-name>, <string-name><given-names>Bryan A.</given-names> <surname>Bartley</surname></string-name>, <string-name><given-names>Jane A.</given-names> <surname>Lieviant</surname></string-name>, and <string-name><given-names>Herbert M.</given-names> <surname>Sauro</surname></string-name></person-group>. <year>2010</year>. <article-title>In-Fusion BioBrick assembly and re-engineering</article-title>, <source>Nucleic Acids Research</source>, <volume>38</volume>: <fpage>2624</fpage>–<lpage>36</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sone</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Yahata</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Sasaki</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Hotta</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kishine</surname></string-name>, <string-name><given-names>J. D.</given-names> <surname>Chesnut</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Imamoto</surname></string-name></person-group>. <year>2008</year>. <article-title>Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: modular construction of multiple cDNA expression elements using recombinant cloning</article-title>, <source>J Biotechnol</source>, <volume>136</volume>: <fpage>113</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tamplin</surname>, <given-names>O. J.</given-names></string-name>, <string-name><given-names>E. M.</given-names> <surname>Durand</surname></string-name>, <string-name><given-names>L. A.</given-names> <surname>Carr</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>Childs</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Hagedorn</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>A. D.</given-names> <surname>Yzaguirre</surname></string-name>, <string-name><given-names>N. A.</given-names> <surname>Speck</surname></string-name>, and <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name></person-group>. <year>2015</year>. <article-title>Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche</article-title>, <source>Cell</source>, <volume>160</volume>: <fpage>241</fpage>–<lpage>52</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Geng</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Yu</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>Zhang</surname></string-name></person-group>. <year>2021</year>. <article-title>Recent Application of Zebrafish Models in Atherosclerosis Research</article-title>, <source>Front Cell Dev Biol</source>, <volume>9</volume>: <fpage>643697</fpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varela</surname>, <given-names>M.</given-names></string-name>, and <string-name><given-names>A. H.</given-names> <surname>Meijer</surname></string-name></person-group>. <year>2022</year>. <article-title>A fresh look at mycobacterial pathogenicity with the zebrafish host model</article-title>, <source>Mol Microbiol</source>, <volume>117</volume>: <fpage>661</fpage>–<lpage>69</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Walton</surname>, <given-names>E. M.</given-names></string-name>, <string-name><given-names>M. R.</given-names> <surname>Cronan</surname></string-name>, <string-name><given-names>R. W.</given-names> <surname>Beerman</surname></string-name>, and <string-name><given-names>D. M.</given-names> <surname>Tobin</surname></string-name></person-group>. <year>2015</year>. <article-title>The Macrophage-Specific Promoter mfap4 Allows Live, Long-Term Analysis of Macrophage Behavior during Mycobacterial Infection in Zebrafish</article-title>, <source>PLoS One</source>, <volume>10</volume>: <fpage>e0138949</fpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wattrus</surname>, <given-names>S. J.</given-names></string-name>, and <string-name><given-names>L. I.</given-names> <surname>Zon</surname></string-name></person-group>. <year>2020</year>. <article-title>A Transgenic System for Rapid Magnetic Enrichment of Rare Embryonic Cells</article-title>, <source>Zebrafish</source>, <volume>17</volume>: <fpage>354</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zacharias</surname>, <given-names>D. A.</given-names></string-name>, <string-name><given-names>J. D.</given-names> <surname>Violin</surname></string-name>, <string-name><given-names>A. C.</given-names> <surname>Newton</surname></string-name>, and <string-name><given-names>R.Y.</given-names> <surname>Tsien</surname></string-name></person-group>. <year>2002</year>. <article-title>Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells</article-title>, <source>Science</source>, <volume>296</volume>: <fpage>913</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Cai</surname></string-name>, <string-name><given-names>E. O.</given-names> <surname>Hall</surname></string-name>, and <string-name><given-names>G. J.</given-names> <surname>Freeman</surname></string-name></person-group>. <year>2007</year>. <article-title>In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations</article-title>, <source>Biotechniques</source>, <volume>43</volume>: <fpage>354</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104182.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lam</surname>
<given-names>Pui-Ying</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Medical College of Wisconsin</institution>
</institution-wrap>
<city>Wisconsin</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study introduces a <bold>useful</bold> toolkit for zebrafish transgenesis, significantly enhancing the flexibility and efficiency of transgene generation for immunological applications. The authors provide supporting evidence through well-designed experiments, demonstrating the toolkit's utility in generating diverse and functional transgenic lines. While the findings are <bold>solid</bold>, additional functional validation and broader comparisons to existing systems would strengthen the overall evidence base and ensure broader relevance to the zebrafish field, thereby increasing the significance of the study.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104182.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors introduce ImPaqT, a modular toolkit for zebrafish transgenesis, utilizing the Golden Gate cloning approach with the rare-cutting enzyme PaqCI. The toolkit is designed to streamline the construction of transgenes with broad applications, particularly for immunological studies. By providing a versatile platform, the study aims to address limitations in generating plasmids for zebrafish transgenesis.</p>
<p>Strengths:</p>
<p>The ImPaqT toolkit offers a modular method for constructing transgenes tailored to specific research needs. By employing Golden Gate cloning, the system simplifies the assembly process, allowing seamless integration of multiple genetic elements while maintaining scalability for complex designs. The toolkit's utility is evident from its inclusion of a diverse range of promoters, genetic tools, and fluorescent markers, which cater to both immunological and general zebrafish research needs. Furthermore, the modular design ensures expandability, enabling researchers to customize constructs for diverse experimental designs. The validation provided in the manuscript is solid, demonstrating the successful generation of several functional transgenic lines. These examples highlight the toolkit's efficacy, particularly for immune-focused applications.</p>
<p>Weaknesses:</p>
<p>While the toolkit's technical capabilities are well-demonstrated, there are several areas where additional validation and examples could enhance its impact. One limitation is the lack of data showing whether the toolkit can be directly used for rapid cloning and testing of enhancers or promoters, particularly cloning them directly from PCR using PaqCI overhangs without needing an entry vector. Similarly, the feasibility of cloning genes directly from PCR products into the system is not demonstrated, which would significantly increase the utility for researchers working with genomic elements.</p>
<p>The authors discuss potential applications such as using the toolkit for tissue-specific knockout applications by assembling CRISPR/Cas9 gRNA constructs. However, they do not demonstrate the cloning of short fragments, such as gRNA sequences downstream of a U6 promoter, which would be an important proof-of-concept to validate these applications. Furthermore, while the manuscript focuses on macrophage-specific promoters, the widely used mpeg1.1 promoter is not included or tested, which limits the toolkit's appeal for researchers studying macrophages and microglia.</p>
<p>Another potential limitation is the handling of sequences containing PaqCI recognition sites. Although the authors discuss domestication to remove these sites, a demonstration of cloning strategies for such cases or alternative methods to address these challenges would provide practical guidance for users.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104182.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Hurst et al. developed a new Tol2-based transgenesis system ImPaqT, an Immunological toolkit for PaqCl-based Golden Gate Assembly of Tol2 Transgenes, to facilitate the production of transgenic zebrafish lines. This Golden Gate assembly-based approach relies on only a short 4-base pair overhang sequence in their final construct, and the insertion construct and backbone vector can be assembled in a single-tube reaction using PaqCl and ligase. This approach can also be expandable by introducing new overhang sequences while maintaining compatibility with existing ImPaqT constructs, allowing users to add fragments as needed.</p>
<p>Strengths:</p>
<p>The generation of several lines of transgenic zebrafish for the immunologic study demonstrates the feasibility of the ImPaqT in vivo. The lineage tracing of macrophages by LPS injection shows this approach's functionality, validating its usage in vivo.</p>
<p>Weaknesses:</p>
<p>(1) There is no quantitative data analysis showing the percentage of off-target based on these 4-bp overhang sequences.</p>
<p>(2) There is no statement for the upper limitation of the expandability.</p>
<p>(3) There is no data about any potential side effect on their endogenous function of promoter/protein of interest with the ImPaqT method.</p>
</body>
</sub-article>
</article>